Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke

Amit Agarwal, Kanupriya Vijay, Krishnamoorthy Thamburaj, Tao Ouyang

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Methotrexate (MTX) is an indispensable antimetabolite for the treatment of oncological and immunological disorders in all age groups. It can be administrated intravenously as well as intrathecally and may be used alone or in combination with other drugs. Chronic leukoencephalopathy is a well-known side effect of MTX, especially in conjunction with intrathecal administration. However, acute neurotoxicity with confusion, disorientation, seizures, and focal deficits may also be seen. This can clinically mimic stroke with restricted diffusion on MRI. However, unlike stroke, there is resolution of clinical and imaging findings within 1-4 weeks. We report two cases of transient leukoencephalopathy following intrathecal methotrexate, with complete clinical and radiological resolutions on follow-up.

Original languageEnglish (US)
Pages (from-to)345-347
Number of pages3
JournalEmergency Radiology
Volume18
Issue number4
DOIs
StatePublished - Aug 1 2011

Fingerprint

Leukoencephalopathies
Methotrexate
Stroke
Antimetabolites
Diffusion Magnetic Resonance Imaging
Seizures
Age Groups
Pharmaceutical Preparations
Therapeutics

Keywords

  • Methotrexate (MTX)
  • Restricted diffusion
  • Stroke

ASJC Scopus subject areas

  • Emergency Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke. / Agarwal, Amit; Vijay, Kanupriya; Thamburaj, Krishnamoorthy; Ouyang, Tao.

In: Emergency Radiology, Vol. 18, No. 4, 01.08.2011, p. 345-347.

Research output: Contribution to journalArticle

Agarwal, Amit ; Vijay, Kanupriya ; Thamburaj, Krishnamoorthy ; Ouyang, Tao. / Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke. In: Emergency Radiology. 2011 ; Vol. 18, No. 4. pp. 345-347.
@article{fc138af5347d4a7c9bcc6eec0ec3ebde,
title = "Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke",
abstract = "Methotrexate (MTX) is an indispensable antimetabolite for the treatment of oncological and immunological disorders in all age groups. It can be administrated intravenously as well as intrathecally and may be used alone or in combination with other drugs. Chronic leukoencephalopathy is a well-known side effect of MTX, especially in conjunction with intrathecal administration. However, acute neurotoxicity with confusion, disorientation, seizures, and focal deficits may also be seen. This can clinically mimic stroke with restricted diffusion on MRI. However, unlike stroke, there is resolution of clinical and imaging findings within 1-4 weeks. We report two cases of transient leukoencephalopathy following intrathecal methotrexate, with complete clinical and radiological resolutions on follow-up.",
keywords = "Methotrexate (MTX), Restricted diffusion, Stroke",
author = "Amit Agarwal and Kanupriya Vijay and Krishnamoorthy Thamburaj and Tao Ouyang",
year = "2011",
month = "8",
day = "1",
doi = "10.1007/s10140-010-0931-6",
language = "English (US)",
volume = "18",
pages = "345--347",
journal = "Emergency Radiology",
issn = "1070-3004",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke

AU - Agarwal, Amit

AU - Vijay, Kanupriya

AU - Thamburaj, Krishnamoorthy

AU - Ouyang, Tao

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Methotrexate (MTX) is an indispensable antimetabolite for the treatment of oncological and immunological disorders in all age groups. It can be administrated intravenously as well as intrathecally and may be used alone or in combination with other drugs. Chronic leukoencephalopathy is a well-known side effect of MTX, especially in conjunction with intrathecal administration. However, acute neurotoxicity with confusion, disorientation, seizures, and focal deficits may also be seen. This can clinically mimic stroke with restricted diffusion on MRI. However, unlike stroke, there is resolution of clinical and imaging findings within 1-4 weeks. We report two cases of transient leukoencephalopathy following intrathecal methotrexate, with complete clinical and radiological resolutions on follow-up.

AB - Methotrexate (MTX) is an indispensable antimetabolite for the treatment of oncological and immunological disorders in all age groups. It can be administrated intravenously as well as intrathecally and may be used alone or in combination with other drugs. Chronic leukoencephalopathy is a well-known side effect of MTX, especially in conjunction with intrathecal administration. However, acute neurotoxicity with confusion, disorientation, seizures, and focal deficits may also be seen. This can clinically mimic stroke with restricted diffusion on MRI. However, unlike stroke, there is resolution of clinical and imaging findings within 1-4 weeks. We report two cases of transient leukoencephalopathy following intrathecal methotrexate, with complete clinical and radiological resolutions on follow-up.

KW - Methotrexate (MTX)

KW - Restricted diffusion

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=80052470598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052470598&partnerID=8YFLogxK

U2 - 10.1007/s10140-010-0931-6

DO - 10.1007/s10140-010-0931-6

M3 - Article

C2 - 21243392

AN - SCOPUS:80052470598

VL - 18

SP - 345

EP - 347

JO - Emergency Radiology

JF - Emergency Radiology

SN - 1070-3004

IS - 4

ER -